This site uses cookies. By continuing to use this site you agree to our use of cookies. To find out more, see our Privacy and Cookies policy.
Skip to the content

IOP A community website from IOP Publishing

Browse events




Conference

Avoiding FDA 483 Observations by Identifying the Root Cause of Deviations - Webinar By GlobalCompliancePanel

About this event

Web site
bit.ly/tzBCf2…
When
8 Dec 2011
Where
Online Training, Wilmington | DE | Zip 19801, United States
Organiser
GlobalCompliancePanel
Contact address
webinars web
online training webinar
Suite 1200
Wilmington
DE
United States
Tel
8004479407
Fax
3022886884
E-mail
webinars@globalcompliance…

Participants will obtain a greater insight into effective investigations and ways to identify the root cause and prevent a similar deviation in the future.

Recent Consent Decrees have included requirements that the firm develop and implement systems that result in timely and complete investigations of deviations and corrective and preventive actions that address the root cause of deviations. FDA 483 and Warning letter observations identify inadequate investigations and follow-up. This webinar addresses adequate investigation of deviations.

The investigation of deviations is clearly a US FDA expectation. The international regulatory expectation for a structured approach to investigations that lead to corrective actions and preventive actions is clearly stated in ICH Q10, Pharmaceutical Quality System, and supported in the FDA Guidance to the Industry, Quality System Approach to Pharmaceutical CGMP Regulations. This course will include a discussion of the Deviation System, what should be investigated and the level of investigation. Several tools that will lead to the identification of the root cause will be discussed. These include: process mapping, brainstorming, cause analysis, cause and effect and the 5 Whys. The investigation system will be integrated with the CAPA and Change Control Systems.

Why you should attend: Recent Consent Decrees have included requirements that the firm develop and implement systems that result in timely and complete investigations of deviations and corrective and preventive actions that address the root cause of deviations. FDA 483 and Warning letter observations identify inadequate investigations and follow-up. This webinar addresses adequate investigation of deviations. Participants will obtain a greater insight into effective investigations and ways to identify the root cause and prevent a similar deviation in the future.

The investigation of deviations is clearly a US FDA expectation. The international regulatory expectation for a structured approach to investigations that lead to corrective actions and preventive actions is clearly stated in ICH Q10, Pharmaceutical Quality System, and supported in the FDA Guidance to the Industry, Quality System Approach to Pharmaceutical CGMP Regulations. This course will include a discussion of the Deviation System, what should be investigated and the level of investigation. Several tools that will lead to the identification of the root cause will be discussed. These include: process mapping, brainstorming, cause analysis, cause and effect and the 5 Whys. The investigation system will be integrated with the CAPA and Change Control Systems.

Areas Covered in the Session:
What should be investigated - Complaints, audit observations, deviations, discrepancies, calibration out-of-tolerances
FDA expectations for investigations
The investigation-problem resolution process - understand the problem, identify possible causes, data collection, data analysis, root cause identification, root cause elimination, solution implementation, verify success
Tools for understanding the process - mapping, critical incident, performance matrix
Tools for understanding the possible causes - brainstorming, is/is not, nominal group
Tools for narrowing the investigation to the most probable cause - data collection, data analysis
Determining the root cause - cause and effect, Fault tree, 5 Whys.
Corrective action
Preventive Action
Verification
Who will benefit: The following individuals and disciplines will benefit from this webinar:
QA document reviewers
QA personnel responsible for reviewing investigations reports
QA personnel responsible for the deviation and investigations systems
Quality and Operations personnel responsible for investigations
Personnel from all units responsible for initiating investigations

Price List:
Live : $245.00
Corporate live : $995.00
Recorded : $295.00

webinars@globalcompliancepanel.com
http://www.globalcompliancepanel.com

Phone: 800-447-9407
Fax: 302-288-6884